Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysisPierre Teira, Jeffery J. Auletta, Minoo Battiwalla et al.|Blood|2016Cited by 554
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric PatientsJoanne Kurtzberg, Sonali Chaudhury, Susan E. Prockop et al.|Transplantation and Cellular Therapy|2013Cited by 248
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment ConsortiumMonica S. Thakar, Michael D. Keller, Brent R. Logan et al.|The Lancet|2023Cited by 123
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca Marsh, Neena Kapoor, Jennifer W. Leiding et al.|Journal of Clinical Immunology|2019Cited by 67
Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in ChildrenJoanne Kurtzberg, Elizabeth Burke, Susan E. Prockop et al.|Transplantation and Cellular Therapy|2020Cited by 65